Healthspan, Not Lifespan: Harvard Researchers on Why Staying Healthy Matters More Than Living Longer

What if the greatest opportunity to prevent cancer, Alzheimer's disease, frailty, and many of the chronic conditions that shorten our lives isn't treating them one by one, but addressing the biology of aging itself?Harvard researchers Raiany Romanni-Klein, PhD and William Mair, PhD join The LIVING Room Podcast to explore why biological aging may be one of the most consequential, and most overlooked, modifiable risk factors in modern medicine, and why rethinking how we age could fundamentally reshape the future of healthcare.For decades, medicine has focused on treating age-related diseases one at a time. But what if the biology driving many of those diseases could itself become a target for prevention?In this conversation, Raiany Romanni-Klein, PhD, and William Mair, PhD, explain why extending healthspan, the years we spend healthy and functional, may matter far more than simply extending lifespan. They unpack the emerging science of biological aging, the ethical and economic questions surrounding longevity research, and why slowing the aging process could have profound implications for cancer, Alzheimer's disease, cardiovascular disease, frailty, and cognitive decline. They also examine the enormous societal cost of chronic disease, the burden placed on unpaid caregivers, and why aging research receives only a fraction of the funding directed toward individual age-related diseases despite its potential to influence many of them simultaneously.In this episode you’ll learn:Why eliminating all cancers would increase life expectancy by only about 2.5 years, while targeting biological aging could have a far greater population-wide impactThe $2 trillion per year economic opportunity of slowing biological aging by just five yearsWhat the 23-year life expectancy gap between two Boston neighborhoods just two miles apart reveals about health inequity and agingWhy aging research receives only a small fraction of the funding devoted to diseases like Alzheimer'sThe difference between lifespan and healthspan, and why that distinction changes everythingThe "41 is the new 40" concept and the extraordinary economic value of making people biologically younger by just one yearRaiany Romanni-Klein, PhD, is a researcher and bioethicist whose work focuses on the ethics, economics, and public policy of human longevity. William Mair, PhD, is a professor at Harvard T.H. Chan School of Public Health whose laboratory studies how metabolism and nutrition influence aging, healthspan, and age-related disease.If you've ever wondered whether aging itself should become a target of medicine, or what the future of longevity science could mean for how we live, work, and stay healthy, this conversation offers one of the most thought-provoking perspectives you'll hear.Timestamps:00:00 Why aging is the health risk no one's treating04:08 Why do we accept aging and decline?05:43 How aging affects work, caregiving, and the economy11:04 Healthspan vs. lifespan: the gap that changes everything12:32 Can aging be treated as a risk factor?17:08 The $2 trillion per year case for slowing aging21:57 Why aging gets pennies while Alzheimer's gets billions26:09 Longevity science, inequality, and who benefits most36:47 What can you do now for healthspan?56:02 Operation Warp Speed for aging — the case for urgencyResources mentioned: Silverlinings Bio: https://silverlinings.bio/ Connect with Raiany Romanni-Klein:Instagram: https://www.instagram.com/raianyromanni/Facebook: https://www.facebook.com/raiany.siLinkedIn: https://www.linkedin.com/in/raiany-romanni-klein-phd-60baa93a/Website: https://www.raianyromanni.com/YouTube: https://www.youtube.com/watch?v=kB1IFGYaYXoX: https://x.com/RaianyRomanniConnect with William Mair:Instagram: https://www.instagram.com/william_mairiLinkedIn: https://www.linkedin.com/in/willmair/Website: https://willmair.com/YouTube: https://www.youtube.com/watch?v=kB1IFGYaYXoX: https://x.com/william_mair